PALO ALTO, Calif., March 11 JazzPharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Samuel R. Saks,M.D., the company's Chief Executive Officer, will provide a corporatepresentation at two upcoming investor conferences.
Dr. Saks will speak at the Cowen and Company 28th Annual Health CareConference at 4:45 p.m. Eastern Time, Monday, March 17, 2008 in Boston.
On Wednesday, March 19, 2008, Dr. Saks will present at the Lehman Brothers11th Annual Global Healthcare Conference at 11:15 a.m. Eastern Time in Miami,Fla.
A live webcast of the presentations may be accessed by visiting theInvestors section of the Jazz Pharmaceuticals website athttp://www.JazzPharmaceuticals.com. A replay will be available on JazzPharmaceuticals' website for two weeks following each presentation.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals is a specialty pharmaceutical company focused onidentifying, developing and commercializing innovative products to meet unmetmedical needs in neurology and psychiatry.
SOURCE Jazz Pharmaceuticals, Inc.